Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cecile Magis-Escurra

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
BMJ Clinical Evidence|February 27, 2015
BronchiectasisCecile Magis-Escurra, Monique He Reijers
Archivos De Bronconeumologia|April 2, 2025
MSCA-RISE: EUSAT-RCS TB Research Consortium: Challenges and Opportunities in Tuberculosis ResearchCecile Magis-Escurra, Juan Espinosa-Pereiro, Luis Gomez Paciello, et al.
Pulmonary Pharmacology & Therapeutics|December 20, 2011
Therapeutic drug monitoring in the treatment of tuberculosis patientsCecile Magis-Escurra, Jossy van den Boogaard, Dirk Ijdema, et al.
Vaccine|April 29, 2015
Focused human gene expression profiling using dual-color reverse transcriptase multiplex ligation-dependent probe amplificationMariëlle C Haks, Jelle J Goeman, Cecile Magis-Escurra, et al.
Respiratory Medicine|September 27, 2017
Treatment and outcome of non-tuberculous mycobacterial pulmonary disease in a predominantly fibro-cavitary disease cohortSanne Zweijpfenning, Stephan Kops, Cecile Magis-Escurra, et al.
Emerging Infectious Diseases|March 12, 2011
Epidemiology of Mycobacterium bovis disease in humans, The Netherlands, 1993-2007Christof J Majoor, Cecile Magis-Escurra, Jakko van Ingen, et al.
AIDS (London, England)|December 24, 2009
Pharmacokinetics of double-dose raltegravir in two patients with HIV infection and tuberculosisDavid M Burger, Cecile Magis-Escurra, Guido El van den Berk, et al.
Frontiers in Immunology|March 24, 2025
The role of neutrophil response in lung damage and post-tuberculosis lung disease: a translational narrative reviewAna Paula Santos, Luciana Silva Rodrigues, Nils Rother, et al.
Clinical Pharmacokinetics|January 24, 2019
Personalized Tuberculosis Treatment Through Model-Informed Dosing of RifampicinStijn W van Beek, Rob Ter Heine, Ron J Keizer, et al.
The European Respiratory Journal|December 10, 2015
Regimens for nontuberculous mycobacterial lung disease lack early bactericidal activityMichiel H C Slaats, Wouter Hoefsloot, Cecile Magis-Escurra, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
BMJ Clinical Evidence|February 27, 2015
BronchiectasisCecile Magis-Escurra, Monique He Reijers
Archivos De Bronconeumologia|April 2, 2025
MSCA-RISE: EUSAT-RCS TB Research Consortium: Challenges and Opportunities in Tuberculosis ResearchCecile Magis-Escurra, Juan Espinosa-Pereiro, Luis Gomez Paciello, et al.
Pulmonary Pharmacology & Therapeutics|December 20, 2011
Therapeutic drug monitoring in the treatment of tuberculosis patientsCecile Magis-Escurra, Jossy van den Boogaard, Dirk Ijdema, et al.
Vaccine|April 29, 2015
Focused human gene expression profiling using dual-color reverse transcriptase multiplex ligation-dependent probe amplificationMariëlle C Haks, Jelle J Goeman, Cecile Magis-Escurra, et al.
Respiratory Medicine|September 27, 2017
Treatment and outcome of non-tuberculous mycobacterial pulmonary disease in a predominantly fibro-cavitary disease cohortSanne Zweijpfenning, Stephan Kops, Cecile Magis-Escurra, et al.
Emerging Infectious Diseases|March 12, 2011
Epidemiology of Mycobacterium bovis disease in humans, The Netherlands, 1993-2007Christof J Majoor, Cecile Magis-Escurra, Jakko van Ingen, et al.
AIDS (London, England)|December 24, 2009
Pharmacokinetics of double-dose raltegravir in two patients with HIV infection and tuberculosisDavid M Burger, Cecile Magis-Escurra, Guido El van den Berk, et al.
Frontiers in Immunology|March 24, 2025
The role of neutrophil response in lung damage and post-tuberculosis lung disease: a translational narrative reviewAna Paula Santos, Luciana Silva Rodrigues, Nils Rother, et al.
Clinical Pharmacokinetics|January 24, 2019
Personalized Tuberculosis Treatment Through Model-Informed Dosing of RifampicinStijn W van Beek, Rob Ter Heine, Ron J Keizer, et al.
The European Respiratory Journal|December 10, 2015
Regimens for nontuberculous mycobacterial lung disease lack early bactericidal activityMichiel H C Slaats, Wouter Hoefsloot, Cecile Magis-Escurra, et al.
Pageof 6